Health ConditionsPertussis, commonly known as whooping cough, is a highly contagious respiratory disease caused by Bordetella pertussis. It is caused specifically by a gram-negative bacterium and spreads via droplet transmission. This fastidious, gram-negative coccobacillus infects the ciliated epithelium of the respiratory tract, where bacterial adhesins and toxins disrupt mucociliary clearance. Bordetella parapertussis has also been associated with this condition in humans.
Classic pertussis is a cough illness that may last for many weeks and is marked by paroxysms of repeated coughs that end with a gasping "whoop." Pertussis is endemic worldwide, with epidemic peaks every 2–5 years, and is highly contagious — up to 90% of household contacts and 50% to 80% of schoolroom contacts will become infected after exposure.
In the prevaccination era, pertussis was a leading cause of infant death. As a result of vaccination, however, the number of cases reported decreased by more than 99% from the 1930s to the 1980s. Nevertheless, the number of pertussis cases is significantly increasing worldwide, hypothetically because of the rapid waning of immunity induced by recent acellular vaccines and adaptation of the bacteria to escape vaccine-induced immunity.
Pertussis is a 6-week disease divided into catarrhal, paroxysmal, and convalescent stages, each lasting 1–2 weeks. The time between exposure and the development of symptoms is on average 7–14 days (ranging 6–20 days), and rarely as long as 42 days.
Young infants may not develop the typical cough, and often present with apnea and cyanosis instead. Pertussis is not usually associated with fever, but it is associated with lymphocytosis, especially among infants and young children.
The primary system affected is the respiratory tract. After the bacteria are inhaled, they initially adhere to the ciliated epithelium in the nasopharynx. Surface proteins of B. pertussis, including filamentous hemagglutinin and pertactin, mediate attachment to the epithelium. The bacteria then multiply. Tracheal cytotoxin (TCT), a fragment of peptidoglycan, kills ciliated epithelial cells in the airway and thereby inhibits the mechanism which clears the airways of mucus and debris.
Pertussis toxins produce most of the systemic manifestations associated with whooping cough, including lymphocytosis and modulation of host immune response. Patients with the disease exhibit various clinical manifestations, including bronchopneumonia, pulmonary hypertension, hypoglycemia, leukocytosis, and paroxysmal coughing.
The cardiovascular system, central nervous system, and gastrointestinal system may all be secondarily affected. CNS complications, such as seizures (1–2% of infants) and encephalopathy, are thought to result from severe, paroxysm-induced cerebral hypoxia and apnea, metabolic disturbances such as hypoglycemia, and small intracranial hemorrhages. The cough from pertussis has been documented to cause subconjunctival hemorrhages, rib fractures, urinary incontinence, hernias, and vertebral artery dissection.
Pertussis complications can include anorexia, dehydration, weight loss, and difficulty sleeping, as well as more severe outcomes including apnea, encephalopathy, pneumonia, pneumothorax, refractory pulmonary hypertension (in infants), rib fractures from severe coughing, and seizures.
Acute dehydration and malnutrition occur in patients with cough that limits food and fluid intake. Failure to thrive is another possible complication of pertussis. The CDC's official clinical reference notes that the most common complication, and the cause of most pertussis-related deaths, is secondary bacterial pneumonia. Young infants are at highest risk for developing pertussis-associated complications; data from 2000–2017 indicate that pneumonia occurred in 13.2% of all reported pertussis cases, and among 18.6% of infants younger than 6 months.
The incidence of pertussis is highest among unvaccinated or incompletely vaccinated infants and young children. Infants under six months old, particularly those who are premature or have low birth weight, face the greatest risk, with an elevated likelihood of complications, hospitalization, and even death.
Multiple interrelated factors may have contributed to post-pandemic pertussis outbreaks, such as the cyclic epidemiology of pertussis, low vaccination coverage rates, waning vaccine-derived immunity, low uptake of boosters, and lack of lifelong protection through regular boosters. Notably, the peak incidence of pertussis has shifted from the infant population to adolescents and adults, who now serve as the primary sources of infection in infants.
Infants born prematurely and patients with underlying cardiac, pulmonary, neuromuscular, or neurologic disease are at high risk for complications of pertussis, such as pneumonia, seizures, encephalopathy, and death. Previous studies have shown that pertussis-related hospitalizations, healthcare burden, concurrent conditions, and risk for death increase with age.
Multivariable logistic regression analysis has shown that being unvaccinated, contact with cases, and living in a house with no window were independent and statistically significant risk factors for pertussis infection. Children with siblings are at higher risk for pertussis.
While B. pertussis infection rates are estimated between 1–10% in the general population, notifications of symptomatic pertussis comprise only 0.01–0.1%, indicating that most individuals clear infections without developing severe clinical symptoms. Research has identified immunogenetic factors that may influence susceptibility. A polymorphism in the Vitamin D receptor (VDR) gene was associated with pertussis; the VDR major allele and its homozygous genotype were more present in the symptomatic pertussis patient cohort compared to the control population cohort, and this allele correlated with the duration of reported pertussis symptoms. These findings highlight the importance of vitamin D3 effects on the immune system and that the delicate balance of pro- and anti-inflammatory immune mechanisms may determine the clinical outcome of B. pertussis infection.
The protective effect of exclusive breastfeeding against pertussis-like illness has been estimated at 74% (95% CI: 38%, 89%). Children younger than six months who were exclusively breastfed and whose mothers were vaccinated against pertussis during pregnancy were five times less likely to develop pertussis-like illness. However, the evidence on breastfeeding and confirmed pertussis is mixed. A separate case-control study found that exclusive breastfeeding was not associated with reduced pertussis compared with partial breastfeeding or artificial feeding (odds ratio: 1.2; 95% CI: 0.31–4.67). The discrepancy may reflect differences in outcome definitions (pertussis-like illness vs. laboratory-confirmed pertussis), study populations, and the complexity of immunoglobulin transfer via breast milk. The authors of the Brazilian case-control study concluded that exclusive breastfeeding protects children under six months from pertussis-like illness and may be enhanced when associated with maternal vaccination.
Acute dehydration and malnutrition occur in patients with cough that limits food and fluid intake, making maintenance of adequate hydration and caloric intake a recognized clinical concern during active illness. Death and serious complications including malnutrition, pneumonia, pulmonary hypertension, seizures, and encephalopathy occur mainly in infants, while older individuals may suffer from sleep deprivation, rib fractures, hernia, and incontinence. The CDC's clinical guidance lists anorexia, dehydration, and weight loss among recognized pertussis complications, underscoring that nutritional integrity is directly challenged during the paroxysmal phase.
Scientific Evidence: The first hint of the significant role of vitamin D on the immune system came from the discovery of the presence of the vitamin D receptor on almost all cells of the immune system. In humans, evidence exists on associations between vitamin D deficiency and impaired immune function, leading to autoimmunity in genetically predisposed people and increased risk for infections; however, data on therapeutic immune effects of vitamin D supplementation when vitamin D levels are already sufficient are lacking.
The pertussis-specific genetic association study described above provides the most direct pertussis-related evidence. Vitamin D3 and the VDR are important regulators of immune activation, and these findings suggest that polymorphisms in the VDR gene may affect immune activation and the clinical outcome of B. pertussis infection. This is observational-genetic evidence only; no clinical trials of vitamin D supplementation as a pertussis-specific intervention have been identified in the peer-reviewed literature.
Meta-analyses of observational studies have demonstrated a link between low vitamin D status and risk of acute respiratory infections generally. Despite promising pre-clinical results, the translation of in vitro observations to solid clinical effects has mostly failed. Nevertheless, the evidence of a link between vitamin D deficiency and adverse outcomes is overwhelming and clearly points towards avoidance of vitamin D deficiency especially in early life. In summary, evidence strength for vitamin D and pertussis specifically is preliminary and mechanistic; no interventional trials targeting pertussis with vitamin D supplementation have been published.
Traditional Use: According to the German Commission E monographs, thyme has traditionally been indicated for bronchitis, whooping cough, upper respiratory catarrh and inflammation, gastrointestinal disorders, and productive cough. The herb is traditionally used in herbal medicine to help relieve coughs (spasmolytic) and the symptoms of bronchitis and mucus buildup of the (upper) respiratory tract (anti-catarrh), a use recognized by the EMA (2014), ESCOP (2003), and multiple reference texts.
Scientific Evidence: Therapeutic properties of thyme derive mainly from the essential oil with antitussive, expectorant, antiseptic, antimicrobial, and anthelmintic properties. Regarding the safe traditional use of thyme herbal preparations and essential oils in productive cough and common cold, and in association with in vitro, in vivo, and clinical data, common thyme is described as safe and efficient in this indication, as noted in the revised final opinion of the EMA. The EMA's classification means that, although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is considered plausible and there is evidence that they have been used safely in this way for at least 30 years.
In an open, multicentre study, 154 children aged 2 months to 14 years with bronchial catarrh or bronchitis were treated daily with 15–30 mL of thyme syrup for a period of 7–14 days; an improvement in the intensity of coughing was reported in 93% of treated patients. This study was uncontrolled (open label with a non-randomized comparator group), limiting the strength of its conclusions. Placebo-controlled trials of thyme for cough in adults with acute bronchitis (assessed in the EMA monograph) provide the strongest available evidence, but no study has been conducted specifically in pertussis patients. Evidence is therefore characterized as traditional use with supportive, but indirect and preliminary, clinical data; it does not constitute proof of efficacy for whooping cough specifically.
Traditional Use: Honey has a long cross-cultural history as a soothing agent for throat irritation and cough symptoms, appearing in folk practices across Europe, the Middle East, and Asia. It has been applied directly, used in warm preparations with herbs, or combined with lemon and ginger as a symptomatic remedy for respiratory illness.
Scientific Evidence: Honey is a sweet, viscous liquid composed of approximately 25 carbohydrates, free amino acids, vitamins, trace elements, and flavonoids. It contains compounds that function as antioxidants and is said to possess antibacterial and anti-inflammatory properties. A Cochrane systematic review (Oduwole et al., 2018) examined honey for acute cough in children. The review included six randomized controlled trials involving 899 children. Studies compared honey with dextromethorphan, diphenhydramine, salbutamol, bromelin, no treatment, and placebo. Beyond three days, honey probably had no advantage over salbutamol or placebo in reducing cough severity, bothersome cough, and impact of cough on sleep (moderate-certainty evidence). Overall evidence quality was rated as low to moderate. There was no strong evidence for or against the use of honey. None of the included trials were conducted specifically in pertussis; all involved non-specific acute cough. Evidence strength: low to moderate for symptomatic cough generally; not studied specifically in pertussis.
Traditional Use: Garlic has been employed across European, Ayurvedic, and traditional Chinese medicine systems as an antimicrobial and expectorant. In the context of whooping cough, it has historically been used as a fresh juice, decoction, or consumed as a food adjunct for its general immune-supportive and antimicrobial properties. There are no studies that use specific herbs, including garlic, to treat whooping cough; these herbs have been used traditionally to treat coughs and strengthen the immune system.
Scientific Evidence: Garlic (Allium sativum) has potent antimicrobial activity due to allicin (diallylthiosulfinate) synthesized by enzyme catalysis in damaged garlic tissues. Allicin gives crushed garlic its characteristic odor and its volatility makes it potentially useful for combating lung infections; the growth inhibitory effect of allicin vapor and allicin in solution has been demonstrated against clinical isolates of lung pathogenic bacteria, including multi-drug resistant strains. However, no studies have tested garlic or allicin against B. pertussis in human clinical trials. Garlic and its organosulfur compounds have many pharmacological properties, including antibacterial, antiviral, anti-inflammatory, anticancer, and antioxidant properties, but published evidence is limited to in vitro and animal studies, with no human trials specifically addressing pertussis. Evidence strength: in vitro and preclinical only; no clinical evidence for pertussis.
Traditional Use: Echinacea, native to North America, was used by Indigenous peoples of the Great Plains for a wide variety of infections and has been employed in Western herbal medicine since the 19th century as an immune stimulant for coughs and upper respiratory infections. It has been proposed in herbal literature for pertussis based on its general immunostimulant profile.
Scientific Evidence: Echinacea extracts are widely used for prevention and treatment of the common cold. A considerable body of research exists, including over 20 randomized trials with more than 3,000 participants, as well as dozens of in vitro and animal studies. Although some consensus exists that echinacea extracts display immunologic activities such as macrophage activation and cytokine expression, investigators disagree about which phytochemicals are involved, and various alkylamides, glycoproteins, polysaccharides and caffeic, cichoric, and caftaric acids are all implicated. No clinical studies have specifically examined echinacea in pertussis patients. Evidence strength for pertussis specifically: absent; general immunomodulatory evidence is preliminary and inconsistent.
Traditional Use: Ginger is used in Ayurvedic, traditional Chinese, and folk European medicine for respiratory complaints including cough, bronchitis, and related conditions. Preparations include decoctions, infusions with honey and lemon, and fresh juice. It has been used alongside other herbs for cough management in children.
Scientific Evidence: While ginger has demonstrated anti-inflammatory and antioxidant properties in preclinical research, no clinical trials specifically examining ginger for pertussis have been identified in the peer-reviewed literature. Claims of benefit in whooping cough circulate in traditional and natural-health contexts but are not supported by pertussis-specific human trial data.
Pertussis poses direct nutritional challenges. Pertussis can lead to hospitalization, pneumonia, dehydration, weight loss, and sleep disturbance. Acute dehydration and malnutrition occur in patients with cough that limits food and fluid intake. Failure to thrive is a possible complication of pertussis. These are established clinical observations documented in the American Academy of Family Physicians literature and CDC resources, indicating that attention to caloric and fluid intake during and after illness is a recognized concern in standard clinical management.
No dietary interventions have been directly tested in pertussis-specific clinical trials. Broader evidence on nutrition and respiratory immune function is relevant as contextual background. Protein/energy malnutrition and micronutrient deficiencies can affect the function of the immune system. Adequate micronutrient status, especially avoidance of vitamin D deficiency in early life, is supported by broader immunological research as discussed above.
Pertussis transmission is highest in the first two weeks after cough onset, a period when it is easily confused with other viral or bacterial respiratory diseases. Factors independently associated with pertussis infection in an epidemiological study included case contact and living in housing without adequate ventilation, as well as being unvaccinated. Adequate ventilation in living environments is therefore identified in the epidemiological literature as a modifiable environmental factor in pertussis risk.
Even as patients start to feel better, they are more vulnerable to other respiratory infections during the convalescent period, as the body is still healing. Avoiding exposure to other pathogens is advised, as contracting another illness may cause coughing fits to return. Older individuals recovering from pertussis may suffer from sleep deprivation, sweating, syncope, rib fractures, hernia, and incontinence — conditions that have implications for rest, nutritional intake, and general health maintenance during recovery.
Sundew (Drosera spp.) is specifically approved by the German Commission E for irritable and whooping cough. Used in European herbal medicine since at least the 17th century for spasmodic respiratory conditions including pertussis, its naphthaquinone constituents (plumbagin, ramentone) show antispasmodic and antitussive activity in animal models, with one fraction found comparable to codeine in suppressing cough impulse.
Thyme (Thymus vulgaris) is one of the most consistently cited botanicals for pertussis across traditional Western herbalism and modern phytotherapy. Nicholas Culpeper recorded it as a specific remedy for 'chin-cough' (whooping cough) in children. The German Commission E and EMA HMPC have approved thyme herb for bronchitis and spasmodic cough. Its key constituents thymol and carvacrol exert antispasmodic, antimicrobial, and expectorant effects in pharmacological studies, and a 2006 peer-reviewed review specifically listed thyme as Commission-E-approved and warranting clinical trials for pertussis.
Vitamin C (ascorbic acid) has the oldest scientific literature for pertussis of any supplement, with clinical reports beginning in 1936 (Otani, Japan). Ormerod (1937, Canadian Medical Association Journal) reported it shortened the paroxysmal stage from weeks to days. Vermillion (1938) reported striking effectiveness in 24 of 26 pertussis cases. Evidence is historical pre-RCT era observational data; no modern RCT has been conducted.
Anise (Pimpinella anisum) is listed in the ADAM Complementary and Alternative Medicine pertussis resource and in the herbal-supplement-resource.com pertussis herb list. The German Commission E approved anise for catarrhs of the upper respiratory tract, and its expectorant and bronchospasmolytic effects are attributed to anethole. It appears as a component in Aviva Romm's published herbal pertussis cough syrup.
Astragalus (Astragalus membranaceus) is listed in the ADAM Complementary and Alternative Medicine pertussis resource and recommended in herbal pertussis protocols as an immune-boosting supportive remedy. Its polysaccharides and astragalosides are well-documented immunomodulators relevant to supporting both humoral and cellular immunity required to clear B. pertussis infection.
Historical European herbal medicine used butterbur for whooping cough (pertussis), an application cited in German phytotherapy literature and attributed to petasin's spasmolytic action on bronchial smooth muscle. No modern clinical trial evidence exists for this use.
Chamomile (Matricaria recutita) is listed in the ADAM Complementary and Alternative Medicine resource for pertussis and is cited by Eclectic and Western herbalists for its antispasmodic and nervine properties, used to calm convulsive coughing particularly in children. The 2006 Abascal and Yarnell peer-reviewed review identified chamomile as a Commission-E-recognized herb relevant to pertussis care.
Coltsfoot has a well-documented traditional use for whooping cough (pertussis), listed across European, American, and Chinese herbal traditions. The root of coltsfoot is noted in US traditional medicine for whooping cough. No clinical trial evidence exists.
Echinacea (Echinacea angustifolia and purpurea) is listed in the ADAM Complementary and Alternative Medicine pertussis resource and cited by Eclectic physicians and modern herbalists for supporting immune function during whooping cough. A 2005 systematic review confirmed its immunomodulatory properties relevant to respiratory infections.
Echinacea purpurea is one of the two Echinacea species most commonly cited in Eclectic and modern herbal pertussis protocols as an immune stimulant and lymphatic agent. It appears in the ADAM Complementary and Alternative Medicine pertussis resource and its species-specific immunological properties are documented in a 2005 evidence-based systematic review.
Elderberry (Sambucus nigra) is referenced in herbal pertussis protocols as an immune-boosting component, appearing directly in Aviva Romm's published pertussis herbal cough syrup formula and in herbalist-recommended immune-boosting formulas for whooping cough. Its anthocyanins have documented immunomodulatory and antiviral properties considered supportive during the prolonged pertussis illness course.
Elecampane (Inula helenium) root has been used in traditional European herbal medicine specifically for whooping cough, documented in 19th- and early 20th-century herbal texts as an expectorant and respiratory tonic. The ADAM Complementary and Alternative Medicine pertussis resource explicitly lists elecampane, and the 2006 Abascal and Yarnell review included it among pertussis botanicals warranting study.
Eucalyptus has been used traditionally in various formulations as a supportive remedy for whooping cough (pertussis), exploiting its expectorant, antispasmodic, and antimicrobial properties. There are no clinical trials specifically evaluating eucalyptus for pertussis; the relationship is based on historical herbal use and pharmacological properties consistent with symptom relief.
Whooping cough (pertussis) is a primary traditional indication for asafoetida in Saudi Arabia, Afghanistan, India, and European herbalism. Its antispasmodic and expectorant properties are considered the basis for reducing paroxysmal coughing fits.
Garlic (Allium sativum) has a long cross-cultural traditional history as a pertussis remedy in traditional Chinese medicine, Ayurveda, and European folk medicine. A 1957 PubMed-indexed paper (PMID 13422206) attempted to treat whooping cough with garlic extract. The ADAM Complementary and Alternative Medicine pertussis resource lists garlic as a recognized remedy, and garlic's allicin has broad antimicrobial activity.
Ginger (Zingiber officinale) is cited in multiple traditional medicine systems and herbalist protocols for pertussis, with reported evidence that it helps with upper respiratory tract infections in children including whooping cough. It appears in traditional whooping cough syrups and integrative medicine sources. Its antimicrobial, anti-inflammatory, and mucolytic properties provide pharmacological plausibility.
Grindelia (Grindelia camporum/squarrosa) is cited specifically in herbal pertussis protocols as an antitussive for whooping cough. Dr. Christopher Hobbs places it in the antitussive herb category for pertussis alongside sundew and yerba santa, and the herbal-supplement-resource.com pertussis page includes it. Traditional North American herbalists used it for spasmodic respiratory conditions including whooping cough.
Horehound has been used traditionally for whooping cough (pertussis) across European, British, and American herbal traditions, owing to its expectorant and antispasmodic properties. The British Pharmacopoeia describes its use as an antispasmodic for whooping cough. No clinical trials in pertussis patients have been conducted.
Hyssop (Hyssopus officinalis) is listed in the ADAM Complementary and Alternative Medicine pertussis resource and in the herbal-supplement-resource.com pertussis herbal list. European herbalists have used it since antiquity as a respiratory expectorant and antispasmodic traditionally recommended for coughs including whooping cough.
Licorice root (Glycyrrhiza glabra) appears in multiple authoritative herbal pertussis protocols as a demulcent, expectorant, anti-inflammatory, and antispasmodic agent for whooping cough. It is cited in Aviva Romm's pertussis herbal syrup formula, Dr. Christopher Hobbs's soothing herbs list for pertussis, and The Wild Pharma's whooping cough herbal guide. The German Commission E approved licorice root for upper respiratory catarrh.
Lobelia (Lobelia inflata) was one of the four principal herbs favored by 19th-century Eclectic physicians specifically for treating pertussis, valued for its antispasmodic and bronchodilatory effects. It is explicitly listed in the ADAM Complementary and Alternative Medicine pertussis resource and the 2006 Abascal and Yarnell peer-reviewed review. It requires careful dosing due to a narrow therapeutic margin.
Marshmallow (Althaea officinalis) root is a classical demulcent cited in multiple authoritative herbal pertussis protocols for soothing inflamed and irritated respiratory membranes during whooping cough. It appears in the ADAM Complementary and Alternative Medicine pertussis resource, Dr. Christopher Hobbs's soothing herbs list, and in Aviva Romm's published pertussis herbal syrup. The German Commission E approved it for dry cough and upper respiratory mucosal irritation.
Mullein (Verbascum thapsus) leaf is widely cited in herbal pertussis protocols as a pulmonary tonic and expectorant that soothes harsh, racking coughs with dry, irritated membranes. Dr. Christopher Hobbs places it in the antitussive category for pertussis, and a 2005 phytotherapy research review documented its antimicrobial, anti-inflammatory, and antitussive properties.
Whooping cough (pertussis) is documented as a traditional indication for P. orientalis in multiple systematic reviews. The plant is listed among conditions treated with extracts in traditional Asian medical systems. Its antitussive and antimicrobial properties provide mechanistic plausibility.
Passionflower (Passiflora incarnata) was favored by 19th-century Eclectic physicians specifically for treating pertussis alongside lobelia, red clover, and sundew. The 2006 Abascal and Yarnell peer-reviewed review listed it among herbs used by physicians before vaccines for pertussis, and it appears in Aviva Romm's published pertussis herbal cough syrup formula.
Peach leaf is specifically cited in Eclectic medicine and traditional botanical references for whooping cough (pertussis). The King's American Dispensatory and multiple botanical catalogues document this use. No modern clinical evidence exists.
Pipsissewa (Chimaphila umbellata) is listed in the herbal-supplement-resource.com pertussis herbal compilation as a traditional remedy used in North American herbal medicine for whooping cough. It was employed historically by Native Americans and Eclectic physicians for respiratory conditions with astringent and tonic effects on respiratory mucous membranes. Evidence is exclusively historical.
Whooping cough (pertussis) is listed among P. tenuifolia's traditional indications in multiple ethnomedical and botanical references. The root's saponin-based expectorant properties have been invoked to explain its traditional use for paroxysmal cough. No modern clinical or preclinical pertussis trials have been published.
Red clover (Trifolium pratense) blossoms were among the four key remedies favored by 19th-century Eclectic physicians specifically for pertussis. The 2006 Abascal and Yarnell peer-reviewed review listed it among pre-vaccine botanical treatments for pertussis. It is referenced as an age-old remedy for whooping cough for its lymphatic, expectorant, and anti-inflammatory properties.
Whooping cough (pertussis) is listed as a traditional indication for red root in Native American folk medicine, Eclectic texts (King's American Dispensatory), and early American herbal literature including Jethro Kloss's Back to Eden. The antispasmodic action is the proposed mechanism. No clinical trials exist.
The German Commission E and ESCOP monographs both include supportive use for whooping cough (pertussis) among thyme's traditional indications, reflecting historical use for the spasmodic cough of pertussis. The EMA assessment notes that indications for pertussis are now classified as traditional rather than well-established, and that expectorants have little evidence for pertussis specifically. The antispasmodic action of thymol provides pharmacological plausibility.
Tylophora is documented in Ayurvedic and Indian folk medicine as a traditional remedy for whooping cough (pertussis). Multiple ethnopharmacological sources list whooping cough among the conditions for which leaves were historically employed across southern and eastern India. No controlled clinical trials for pertussis have been published.
Valerian root (Valeriana officinalis) is cited in multiple herbal pertussis protocols as a calming nervine that eases the neurological component of the cough reflex, reduces anxiety, and promotes sleep during the exhausting paroxysmal stage. Dr. Christopher Hobbs places it in the antispasmodic category for pertussis, and herbalist clinical guides recommend it specifically to calm cough-reflex nerves in children with whooping cough.
Go back